This inventor holds 1 USPTO granted patent. Top assignee: Gunma University. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Hiroshi Shibata: Innovator in Diabetes and Obesity Treatment
Introduction
Hiroshi Shibata is a notable inventor based in Maebashi, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of diabetes and obesity. His innovative approach has led to the development of a unique method aimed at lowering blood glucose levels.
Latest Patents
Hiroshi Shibata holds a patent for a method of lowering blood glucose and treating diabetes and obesity. The patent describes a compound represented by the general formula (I), which is administered to subjects suffering from these conditions. In this formula, R and R independently represent an aliphatic hydrocarbon group having 1 to 10 carbon atoms or a phenyl group. Additionally, arbitrary hydrogen atoms on the aliphatic hydrocarbon group and the phenyl group may be replaced by halogen. The formula also includes halogen and hydrogen components, showcasing the complexity and potential effectiveness of the treatment.
Career Highlights
Hiroshi Shibata is affiliated with Gunma University, where he continues to engage in research and development. His work has garnered attention for its potential impact on public health, particularly in managing diabetes and obesity, which are prevalent issues worldwide.
Collaborations
Hiroshi Shibata collaborates with Yuzuru Kubohara, contributing to the advancement of their research initiatives. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Hiroshi Shibata's contributions to the field of diabetes and obesity treatment through his innovative patent highlight his role as a significant inventor. His work at Gunma University and collaboration with fellow researchers further emphasize the importance of innovation in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
